Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Caffeic Acid phenethyl ester inhibits epithelial-mesenchymal transition of human pancreatic cancer cells.

Chen MJ, Shih SC, Wang HY, Lin CC, Liu CY, Wang TE, Chu CH, Chen YJ.

Evid Based Complement Alternat Med. 2013;2013:270906. doi: 10.1155/2013/270906. Epub 2013 Apr 4.

2.

The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines.

Kimura-Tsuchiya R, Ishikawa T, Kokura S, Mizushima K, Adachi S, Okajima M, Matsuyama T, Okayama T, Sakamoto N, Katada K, Kamada K, Uchiyama K, Handa O, Takagi T, Yagi N, Naito Y, Itoh Y.

J Clin Biochem Nutr. 2014 Jul;55(1):56-61. doi: 10.3164/jcbn.14-8. Epub 2014 May 13.

3.

Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.

Sun XD, Liu XE, Huang DS.

Oncol Rep. 2013 Jun;29(6):2401-7. doi: 10.3892/or.2013.2385. Epub 2013 Apr 4.

PMID:
23563640
4.

Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells.

Chang ZG, Wei JM, Qin CF, Hao K, Tian XD, Xie K, Xie XH, Yang YM.

Dig Dis Sci. 2012 May;57(5):1181-9. doi: 10.1007/s10620-012-2036-4. Epub 2012 Jan 21.

PMID:
22271412
5.

Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.

Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD.

J Exp Clin Cancer Res. 2009 Feb 26;28:28. doi: 10.1186/1756-9966-28-28.

6.
7.

SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.

Nishioka R, Itoh S, Gui T, Gai Z, Oikawa K, Kawai M, Tani M, Yamaue H, Muragaki Y.

Exp Mol Pathol. 2010 Oct;89(2):149-57. doi: 10.1016/j.yexmp.2010.05.008. Epub 2010 Jun 1.

PMID:
20576520
8.

Propolis inhibits TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells via PPARγ activation.

Kao HF, Chang-Chien PW, Chang WT, Yeh TM, Wang JY.

Int Immunopharmacol. 2013 Mar;15(3):565-74. doi: 10.1016/j.intimp.2012.12.018. Epub 2013 Jan 14.

PMID:
23328619
9.

Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model.

Boreddy SR, Srivastava SK.

Oncogene. 2013 Aug 22;32(34):3980-91. doi: 10.1038/onc.2012.413. Epub 2012 Sep 17.

10.

Caffeic acid phenethyl ester induces apoptosis of human pancreatic cancer cells involving caspase and mitochondrial dysfunction.

Chen MJ, Chang WH, Lin CC, Liu CY, Wang TE, Chu CH, Shih SC, Chen YJ.

Pancreatology. 2008;8(6):566-76. doi: 10.1159/000159843. Epub 2008 Sep 29.

PMID:
18824880
11.

EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.

Liu LC, Tsao TC, Hsu SR, Wang HC, Tsai TC, Kao JY, Way TD.

J Agric Food Chem. 2012 Oct 3;60(39):9863-73. doi: 10.1021/jf303690x. Epub 2012 Sep 19.

PMID:
22957988
12.

[Sunitinib suppresses migration of ovarian cancer cells through negative modulation of TGF-β-mediated epithelial-mesenchymal transition].

Chen ZB, Chang LL, Zhou TY, Wang DD, Chen Y, Zhao PG, Zhu H.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Sep;44(5):479-85. Chinese.

PMID:
26713520
13.

CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling.

Tseng JC, Lin CY, Su LC, Fu HH, Yang SD, Chuu CP.

Oncotarget. 2016 Jun 21;7(25):38010-38024. doi: 10.18632/oncotarget.9380.

14.

TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells.

Itoigawa Y, Harada N, Harada S, Katsura Y, Makino F, Ito J, Nurwidya F, Kato M, Takahashi F, Atsuta R, Takahashi K.

Respir Res. 2015 Apr 8;16:48. doi: 10.1186/s12931-015-0207-5.

15.

The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer.

Wu Y, Sato F, Yamada T, Bhawal UK, Kawamoto T, Fujimoto K, Noshiro M, Seino H, Morohashi S, Hakamada K, Abiko Y, Kato Y, Kijima H.

Int J Oncol. 2012 Oct;41(4):1337-46. doi: 10.3892/ijo.2012.1559. Epub 2012 Jul 18.

PMID:
22825629
16.

Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.

Sehrawat A, Singh SV.

Cancer Prev Res (Phila). 2011 Jul;4(7):1107-17. doi: 10.1158/1940-6207.CAPR-10-0306. Epub 2011 Apr 4.

17.

N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.

Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, Kawaguchi Y, Fujimoto K, Hosotani R, Imamura M.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4125-33.

18.

Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.

Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, Ham J, Jang HJ, Kang KS, Ko H.

Toxicology. 2014 Aug 1;322:23-33. doi: 10.1016/j.tox.2014.04.002. Epub 2014 May 2.

PMID:
24793912
19.

JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.

Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT.

Int J Oncol. 2014 May;44(5):1643-51. doi: 10.3892/ijo.2014.2310. Epub 2014 Feb 21.

PMID:
24573038
20.

Supplemental Content

Support Center